Protozoal encephalomyelitis in horses: 82 cases (1972-1986).

The researchers have conducted a study on 82 cases of protozoal encephalomyelitis in horses over a span of 14 years. They found that treatment with certain drugs decreased the number of instances where protozoan parasites were detected in the horse’s central nervous system (CNS) during autopsies. The most affected were younger horses, particularly male and Standardbred horses.

Study Overview

• The research involves the compilation and review of medical records of 82 horses showing clinical symptoms of neurologic diseases and specifically with histological indications of protozoal encephalomyelitis, a condition which involves an inflammation of the brain and spinal cord caused by protozoan parasites.
• The timeframe of the study stretched from 1972 to 1986, providing a substantial period to identify trends or patterns.

Findings and Implications

• Treatment with corticosteroids did not affect the presence of the protozoan parasite in the horse’s central nervous system (CNS). This suggests that corticosteroids, often used to reduce inflammation, do not affect the presence or activity of the invading parasite causing the inflammation.
• Conversely, treatment with trimethoprim-sulfonamide alone or used along with pyrimethamine resulted in a reduced number of instances where the protozoan parasite was detected post-mortem. This implies that these medications potentially have a positive effect against such parasites, aiding in their eradication or the suppression of their activity.
• The data shows a slightly higher prevalence in younger horses, with the mean age of affected horses being about 3.62 years. This suggests that younger horses may be more susceptible to this condition, although the reason for this is not directly addressed in the abstract.
• The study also noted an overrepresentation of male horses and those of the Standardbred breed among the affected, when compared with the total hospital population of horses studied during the same period. This indicates that these particular demographics may potentially face a higher risk of developing protozoal encephalomyelitis.